For people with lung problems like COPD, taking a deep breath can be difficult without the help of an inhaler. But are those inhalers always safe?

Johns Hopkins-led research suggests using Respimat Soft Mist Inhaler to deliver tiotropium (Spiriva) to chronic obstructive pulmonary disorder (COPD) patients is linked to a 52 percent increase in risk of death.

Patients who suffer from chronic obstructive pulmonary disease (COPD) face a greater risk of developing shingles compared to those without COPD. The risk becomes even greater for those taking oral steroids for COPD.